Filtering
Week: Week 70 ×
Attack target: The Presidency ×
Trait: Administrative agencies are deregulated or captured by private interests ×
Clear all
☆ Save this search
Tier 1 carried by a primary record
Corroborated 2+ independent news desks
Every result is verified and democracy-related.
Open an event to see its evidence. Attack and trait tags link to their definitions
May 19, 2026 The Trump administration launched TrumpRx and expanded a Medicare pilot for obesity drugs Tier 1 · Primary Power and Authority
The moves used executive health-policy power to shape drug access while raising conflict concerns because of the president's financial ties to drugmakers.
Independently corroborated by2 independent news desks
Supporting reportingSurfacings — do not carry alone
Supporting reports
- Launch of TrumpRx Direct-to-Consumer Drug Sales Website — In February 2026, the Trump administration launched TrumpRx, a direct-to-consumer drug sales website aimed at reducing prescription drug costs.
- Trump Administration Expands Access to Obesity Treatments — The Trump administration initiated a pilot program through the Centers for Medicare and Medicaid Services to expand access to GLP-1 medications, including Eli Lilly's Foundayo and Zepbound KwikPen, for Medicare patients.
Attacks
Verified: Tier 1 primary record
Week 70 – 2026-05-16–2026-05-22
wk70_PA_008